Variation in neurocognitive and psychological symptoms between children and adults treated with elexacaftor/tezacaftor/ivacaftor (ETI)

被引：0
|
作者：
Barker, Jessica [1 ]
Krishan, Smriti [1 ]
Thomsen, Amanda [1 ]
Owens, Louisa [1 ,2 ]
Prentice, Bernadette [1 ,2 ]
机构：
[1] Sydney Childrens Hosp, Sydney, NSW, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
103
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [1] Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor
    Baroud, Evelyne
    Chaudhary, Nivedita
    Georgiopoulos, Anna M.
    PEDIATRIC PULMONOLOGY, 2023, 58 (07) : 1920 - 1930
  • [2] The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
    Scully, Kevin J.
    Marchetti, Peter
    Sawicki, Gregory S.
    Uluer, Ahmet
    Cernadas, Manuela
    Cagnina, Rebecca E.
    Kennedy, John C.
    Putman, Melissa S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 258 - 263
  • [3] Screening for mood and behavioural changes in children on Elexacaftor/Tezacaftor/Ivacaftor (ETI)
    Barker, J.
    Krishan, S.
    Owens, L.
    Prentice, B.
    RESPIROLOGY, 2024, 29 : 225 - 225
  • [4] Growth, Body Composition, and Strength of Children With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor (ETI)
    Boat, Thomas
    Hossain, Md Monir
    Nakamura, Aisaku
    Hjelm, Michelle
    Hardie, William
    Wackler, Matthew
    Amato, Alyssa
    Dress, Carolyn
    PEDIATRIC PULMONOLOGY, 2025, 60 (01)
  • [5] Elexacaftor/Tezacaftor/Ivacaftor (ETI) in Combination With Tacrolimus After Lung Transplant
    Guimbellot, J. S.
    Acosta, E. P.
    Ryan, K. J.
    Chalamalla, A.
    Baker, E.
    Bartlett, L.
    Bergeron, J.
    Turner, G.
    Ramos, K. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [6] Neuropsychiatric symptoms with elexacaftor/tezacaftor/ivacaftor: What does this mean for children?
    Pham, Hiep
    Vandeleur, Moya
    Ranganathan, Sarath
    PEDIATRIC PULMONOLOGY, 2024, 59 (03) : 537 - 539
  • [7] IMPACT OF CF GENOTYPE ON EFFICACY OF ELEXACAFTOR-TEZACAFTOR-IVACAFTOR (ETI) IN PWCF
    Sheikh, Shahid I.
    Holtzlander, Melissa
    Eisner, Mariah
    Gushue, Courtney A.
    Imran, Sehyr
    Palacios, Sabrina J.
    Mull, Eric S.
    Paul, Grace
    May, Anne
    McCoy, Karen S.
    CHEST, 2024, 166 (04) : 164A - 165A
  • [8] EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON CHRONIC SINONASAL SYMPTOMS IN ADULTS WITH CYSTIC FIBROSIS
    DiMango, E.
    Overdevest, J.
    Keating, C.
    Francis, Fracasso S.
    Dansky, D.
    Gudis, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S213 - S213
  • [9] Reduced dose prescribing of elexacaftor/tezacaftor/ivacaftor (ETI) in children with cystic fibrosis: Assessing clinical impact
    Thomsen, Amanda
    Belessis, Yvonne
    Bell, Rhonda
    Coward, Emma
    Fulvia, Annice
    Katz, Tamarah
    McBride, Jamie
    Prentice, Bernadette
    Plush, Leanne
    Strachan, Roxanne
    Watkins, Sarah
    Chuang, Sandra
    RESPIROLOGY, 2024, 29 : 40 - 40
  • [10] Lack of Response to ETI Therapy (Elexacaftor/Tezacaftor/Ivacaftor) despite adequate Drug Levels
    Renate, Ruppel
    Christina, Tremel
    Julia, Sobel
    Joachim, Woelfle
    Sabina, Schmitt-Grohe
    KLINISCHE PADIATRIE, 2023, 235 (02): : 117 - 117
12345